Your AI-Trained Oncology Knowledge Connection!


Video

Dr. DiNome on Surgical Approaches in Patients With Breast Cancer

Maggie DiNome, MD, associate professor of surgery, University of California, Los Angeles Medical Center, discusses the evolution of surgical approaches in patients with breast cancer.

Maggie DiNome, MD, associate professor of surgery, University of California, Los Angeles Medical Center, discusses the evolution of surgical approaches in patients with breast cancer.

Physicians are understanding that more surgery is not necessarily better surgery. Patients don’t get a better survival outcome by doing a bigger surgery, and they also don’t get a worse survival outcome with a smaller surgery, DiNome says. Most patients are now surviving breast cancer, certainly early-stage breast cancer. Physicians are finding it earlier and treating it better. Systemic therapies are much more effective, so patients are living for long periods of time.

It’s incumbent on surgeons to be focused on quality of life and survivorship issues for patients. Surgeons want to restore a woman’s sense of self-worth, their femininity, and how they feel about themselves. Surgeons want to preserve the breast if it can be preserved, and if it needs to be removed, making it look as natural as possible. That’s the direction that surgery is headed. Surgeons are focusing on the aesthetic outcomes of breast cancer surgery. Surgeons in conjunction with other medical oncologists are working together to get both a good survival outcome as well as good aesthetic outcome, states DiNome.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Related Videos
MIRZA
Guru P. Sonpavde, MD, medical director for Genitourinary (GU) Oncology, assistant director of the Clinical Research Unit, and the Christopher K. Glanz Chair for Bladder Cancer Research at AdventHealth Cancer Institute,
Eunice Wang Lab | Roswell Park Comprehensive Cancer
Mark D. Tyson II, MD, MPH, Mayo Clinic
Alicia Morgans, MD, MPH of Dana-Farber Cancer Institute
Julie Lang, MD
Dr Krishnan on Advancing T-Cell Therapies and Novel Targets Reshape Myeloma Treatment Landscape
Syed Abbas Ali, MBBS, an assistant professor of oncology at Johns Hopkins School of Medicine and Sidney Kimmel Comprehensive Cancer Center
Oleg Gluz, MD, chief physician, Breast Cancer Niederrhein
R. Lor Randall, MD, FACS